The GW Cancer Center recently co-hosted a workshop on improving LGBTQ+ health. More than 60 attendees gathered to discuss wellness, cancer care needs and inclusion in research.
Interested in imaging your cancer cells? An IVIS Lumina III series imaging system is available for use in Ross Hall. The platform provides a sensitive imaging system for fluorescent and bioluminescent imaging.
A team at GW was awarded more than $1.8M from NIH to study the mechanisms driving dysregulation splicing factor expression. The findings in the study may help explain prostate cancer disparities.
Catherine Bollard, MD, associate center director for translational research and innovation at the GW Cancer Center, oversees clinical and research programs that aim to bring the latest cell therapies to patients. Check out her
Q&A to learn more about her work and vision for innovation at the GW Cancer Center.
